Top compounds associated with response to NTMT1


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.16 1e-05
mRNA BIBW2992 CTRPv2 pan-cancer AAC -0.16 1e-05
mRNA ABT-737 CTRPv2 pan-cancer AAC -0.16 1e-05
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.16 2e-05
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.15 2e-05
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA HLI 373 CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA YK 4-279 GDSC1000 pan-cancer AAC 0.13 0.0002
mRNA neratinib CTRPv2 pan-cancer AAC -0.13 0.0002
Download CSV